Media conglomerate Time Warner Inc. will change its governance and compliance rules to improve oversight and boost board independence after a federal judge approved a settlement Wednesday in a series of derivative lawsuits.
An International Trade Commission administrative law judge has ruled that Bavarian Nordic's patents for a smallpox vaccine are invalid, which may give rival Acambis a leg up in a battle over millions in U.S. anti-terror funding.
Aggressive patent holding company Ronald A. Katz Technology Licensing LP has snared Time Warner Cable Inc. and a host of other corporate giants in a suit, alleging infringement of more than two dozen of its patents covering an interactive call-processing system.
Water-filter maker 3M has sprayed subsidiaries of Clorox Co. and retailer Sears Roebuck & Co. with a lawsuit, claiming they violated two of its patents covering a cartridge-based water purification and filtration system.
At least 12 prospective buyers have bid for Tower Records, the unit of MTS Inc. that declared bankruptcy in August, according to an investment banker for the record store.
A spate of objections has peppered the docket of Owens Corning’s Chapter 11 case in recent days, as a Sept. 18 confirmation hearing on the bankrupt fiberglass maker’s reorganization plan approaches.
Swiss-based engineering giant ABB Ltd. said Friday it had resolved asbestos claims against Lummus, its U.S. subsidiary, in a move that puts to rest the unit’s asbestos liabilities and opens the door for its sale.
Valassis Communications Inc. has sued Advo Inc. to pull out of its $1.3 billion proposed merger deal combining the two advertising and direct-marketing companies, claiming that Advo misrepresented its financial health and neglected to disclose internal control deficiencies.
Lending a boost to Ranbaxy Laboratories’ global crusade, a Norwegian court has denied Pfizer Inc.’s claim that the Indian drug maker has infringed two patents related to blockbuster cholesterol drug Lipitor.
The debtors in J.L. French’s bankruptcy case decided to withdraw, without prejudice, objections brought against the auto parts company’s claims on Monday.
Danisco subsidiary Genencor International Inc. announced Friday that it was withdrawing Spezyme Ethyl—an alpha amylase enzyme used in ethanol production—from the market.
On Monday, the U.S. Food and Drug Administration denied an appeal from drug maker EPIX Pharmaceuticals Inc. to avoid a second round of trials for Vasovist, an injectible product already approved in Europe for use in magnetic resonance imaging (MRI).
A federal judge ruled Thursday that Finova Capital Corp. will have to hand back about $95 million to Thaxton Group Inc., a bankrupt operator of small loan offices.
Real estate developer Mills Corp. deliberately ignored warnings from its outside auditor about faulty accounting practices, according to a lawsuit filed against the company by its former CEO.
Wyeth subsidiary Genetics Institute has sued Baxter Healthcare Corp. for breach of contract regarding the hemophilia drug Recombinate.
Tower Records Inc., which filed for Chapter 11 last week, has asked the bankruptcy court for permission to retain O’Melveny & Myers LLP as its co-counsel.
DLA Piper Rudnick Gray Cary US LLP has nabbed another seasoned antitrust attorney to join the firm’s litigation practice group as a partner in the Philadelphia office.
The Chicago Board Options Exchange called off merger discussions with the Chicago Board of Trade, just a few hours before the CBOT lodged a lawsuit against the options exchange.
Nearly three months after Riverstone Networks Inc. asked for court approval to revamp an old shareholder lawsuit settlement, a federal judge has given the green light to the bid, enabling the bankrupt ethernet provider to recoup nearly $1 million in fees originally paid to shareholders’ lawyers.
Looking to avoid the “cost and burden” of a shareholder lawsuit, the director of Bradley Pharmaceuticals Inc. gave up his post, but was subsequently re-elected to the board after another director resigned.